Evinacumab: First Approval

Markham, A

Markham, A (corresponding author), Springer Nat, Private Bag 65901, Auckland 0754, New Zealand.

DRUGS, 2021; 81 (9): 1101

Abstract

The recombinant human monoclonal antibody evinacumab (evinacumab-dgnb, EVKEEZA (TM)) is an angiopoietin-like protein three (ANGPTL3) inhibitor that ha......

Full Text Link